The MAPK and NF-κB signaling pathways activate IL-1β–induced cancer cell migration and invasion, and inhibition of IL-1β–induced migration and invasion by an inhibitor or RNAi reduces cancer cell migration and invasion [48]. The gene discussed is NFKB1; the disease is cancer.